Internal Medicine, Infectious Disease · Centreville, VA
NPI
1265489868
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
13890 Braddock Rd Ste 206
Centreville, VA, 20121
Phone (703) 758-2664
Groups this clinician bills Medicare through
Medicare paid, 2024
$66K
685 services
Medicare patients, 2024
245
Average age 76
Drug cost, 2024
$825K
761 prescriptions
Company payments, 2025
$2,734
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Henry H Rhee was code 99214 (office e&m - established), 261 times for 102 patients. In total Henry H Rhee billed 685 services in 12 codes, and Medicare paid $66K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 261 | 102 | $112.74 | $29K |
| 99232 Hospital E&M - Subsequent | Facility | 239 | 83 | $65.54 | $16K |
| 99204 Office E&M - New | Office | 71 | 71 | $146.55 | $10K |
| 99222 Hospital E&M - Initial | Facility | 36 | 36 | $104.80 | $3,773 |
| 99442 Telephone Services | Office | 32 | 19 | $79.83 | $2,555 |
By year: 2022 $97K for 1,074 services; 2023 $115K for 1,243 services; 2024 $66K for 685 services.
Medicare prescription drug claims, 2024
In 2024, the drug Henry H Rhee prescribed most often to Medicare patients was Daptomycin, with 110 prescriptions and refills. In total Henry H Rhee wrote 761 Medicare prescriptions that cost $825K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Daptomycin Generic | 110 | 110 | 23 | $52K |
| Meropenem Generic | 80 | 80 | 13 | $7,098 |
| Ertapenem Ertapenem Sodium | 54 | 54 | 14 | $27K |
| Imipenem-Cilastatin Sodium Imipenem/Cilastatin Sodium | 43 | 43 | Under 11 | $13K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 34 | 34 | Under 11 | $138K |
| Ceftriaxone Ceftriaxone Sodium | 30 | 30 | Under 11 | $2,790 |
| Doxycycline Hyclate Generic | 25 | 25 | Under 11 | $536 |
| Micafungin Micafungin Sodium | 20 | 20 | Under 11 | $7,155 |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 19 | 19 | Under 11 | $3,373 |
| Methenamine Hippurate Generic | 19 | 52 | 12 | $2,484 |
| Vancomycin Hcl Generic | 18 | 25 | Under 11 | $2,119 |
| Amoxicillin Generic | 17 | 21 | Under 11 | $51.01 |
| Cefazolin Sodium Generic | 15 | 15 | Under 11 | $911 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 14 | 14 | Under 11 | $221 |
| Juluca Dolutegravir/Rilpivirine | 13 | 13 | Under 11 | $46K |
Brand drugs: 151 claims; generic drugs: 610 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Henry H Rhee $2,734 ($2,734 in general payments such as food, travel and fees) from 14 companies. The largest payer was Gilead Sciences, Inc. with $552.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 22 | $552 |
| ViiV Healthcare Company GSK | 21 | $449 |
| Abbvie Inc. ABBV | 18 | $448 |
| Shionogi Inc 4507.T | 25 | $336 |
| Merck Sharp & Dohme LLC MRK | 8 | $215 |
| Melinta Therapeutics, LLC | 9 | $191 |
| La Jolla Pharmaceutical Company | 6 | $162 |
| Theratechnologies Inc. THTX | 4 | $126 |
| Aimmune Therapeutics, Inc. | 3 | $90.11 |
| Insmed, Inc. INSM | 3 | $72.27 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.